Recent Posts
- The Danish Medicines Agency has approved the phase I clinical trial with cell treatment of children with autism and leaky gut syndrome
- Ethical approval for the ASC phase I clinical trial in children with autism and leaky gut syndrome
- Cell2Cure has received approval from the Danish Medicinal Agency for a clinical Phase I study
- The Cell2Cure core technology has been granted patent rights in Australia
- Patient enrollment finalized in the Phase II trial testing ASC in Sjögren’s syndrome
Recent Comments